1 |
Sarkissian, C. N., Z. Shao, F. Blain, R. Peevers, H. Su, R. Heft, T. M. Chang, and C. R. Scriver. 1999. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia-lyase. Proc. Natl. Acad. Sci. (USA) 96, 2339-2344
DOI
ScienceOn
|
2 |
McHutchison, J. G, 1. M. Blatt, R. Ponnudurai, K. Goodarzi, J. Russell, and A Conrad. 1999. Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection. J. Med. Virol. 57, 351-355
DOI
ScienceOn
|
3 |
Medical Research Council (UK). 1993. Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. BMJ 306, 115-119
DOI
ScienceOn
|
4 |
Moats, R. A, R. Koch, K. Moseley, P. Guldberg, F. GuttIer, R. G Boles, and M. D. Nelson. 2000. Brain phenylalanine concentration in the management of adults with phenylketonuria. J. Inherit. Metab. Dis. 23, 7-14
DOI
ScienceOn
|
5 |
Rao, P. V., K. Moore, and G H. Towers. 1967. Degradation of aromatic amino acids by fungi. II. Purification and properties of phenylalanine ammonia-lyase from Ustilago hordei. Can. J. Biochem. 45, 1863-1872
DOI
|
6 |
Report of Medical Research Council Working Party on Phenylketonuria. 1993. Recommendations on the dietary management of phenylketonuria. Arch. Dis. Child 68, 426-427
DOI
ScienceOn
|
7 |
Sarkissian, C. N., D. M. Boulais, J. D. McDonald, and C. R. Scriver. 2000. A heteroallelic mutant mouse model: a new orthologue for human hyperphenylalaninemia. Mol. Genet. Metab. 69, 188-194
DOI
ScienceOn
|
8 |
Calabrese, J. C., D. B. Jordan, A Boodhoo, S. N. Sariaslani, and T. Vannelli. 2004. Crystal structure of phenylalanine ammonia-lyase: multiple helix dipoles implicated in catalysis. Biochemistry 43, 11403-11416
DOI
ScienceOn
|
9 |
Cockburn, F. and B. J. Clark. 1996. Recommendations for protein and amino acid intake in phenylketonuric patients. Eur. J. Pediatr. 155, 125-129
DOI
|
10 |
Koukot J. and E. E. Conn. 1961. The metabolism of aromatic compounds in higher plans. IV. Purification and properties of the phenylalanine deaminase of Hordeum vulgare. J. BioI. Chem. 236, 2692-2698
|
11 |
Levy, H. 1999. Phenylketonuria; old disease, new approach to treatment. Proc. Natl. Acad. Sci. (USA) 96, 1811-1813
DOI
ScienceOn
|
12 |
Liu, L X. Jia, J. Zhang, H. Xiang, W. Hu, and Y. Zhou. 2002. Study on a novel strategy to treatment of phenylketonuria. Artif. Cells Blood Substit. Immobil. Biotechnol. 30, 243-257
DOI
ScienceOn
|
13 |
Donlun, J., H. Levy, and C. R. Scriver. 2004. The metabolic and molecular basis of inherited disease. Chap. 77, McGraw-Hilt New York
|
14 |
Gilbert, H. J., I. N. Clarke, R. K. Gibson, J. R. Stephenson, and M. Tully. 1985. Molecular cloning of the phenylalanine ammonia lyase gene from Rhodosporidium toruloides in Escherichia coli K-12. J. Bacteriol. 161, 314-320
|
15 |
Gilbert, H. J. and G W. Jack. 1981. The effect of proteinases on phenylalanine ammonia-lyase from the yeast Rhodotorula glutinis. Biochem. J. 199, 715-723
|
16 |
Gilbert, H. J. and M. Tully. 1985. Protection of phenylalanine ammonia-lyase from proteolytic attack. Biochem. Biophys. Res. Commun. 131, 557-563
DOI
ScienceOn
|
17 |
Hoskins, J. A, S. B. Holliday, and A M. Greenway. 1984. The metabolism of cinnamic acid by healthy and phenylketonuric adults: a kinetic study. Biomed. Mass Spectrum. 11, 296-300
DOI
ScienceOn
|
18 |
Hoskins, J. A, G Jack, H. E. Wade, R. J. Peiris, E. C. Wright, D. J. Starr, and J. Stern. 1980. Enzymatic control of phenylalanine intake in phenylketonuria. Lancet 1, 392-394
|
19 |
Kim, W., H. Erlandsen, S. Surendran, R. C. Stevens, A Gamez, K. Michals-Matalon, S. K. Tyring, and R. Matalon. 2004. Trends in enzyme therapy for phenylketonuria. Mol. Ther. 10, 220-224
DOI
ScienceOn
|
20 |
Abell, C. W. and R. S. Shen. 1987. Phenylalanine ammo-nia-Iyase from the yeast Rhodotorula glutinis. Methods Enzymol. 142, 242-249
DOI
|
21 |
Anson, J. G, H. J. Gilbert, J. D. Oram, and N. P. Minton. 1987. Complete nucleotide sequence of the Rhodosporidium toruloides gene coding for phenylalanine ammonia-lyase. Gene 58, 189-199
DOI
ScienceOn
|
22 |
Bourget, L. and T. M. Chang. 1986. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model. Biochim. Biophys. Acta. 883, 432-438
DOI
ScienceOn
|
23 |
Bourget, L., and T. M. Chang. 1989. Effects of oral administration of artificial cells immobilized phenylalanine ammonia- lyase on intestinal amino acids of phenylketonuric rats. Biomater. Artif Cells Artif Organs. 17, 161-181
|
24 |
Brannigan, J. A and A J. Wilkinson. 2002. Protein engineering 20 years on. Nat. Rev. Mol. Cell BioI. 3, 964-970
DOI
ScienceOn
|